Impact of weight on immune cell counts among HIV-infected persons

Clinical and Vaccine Immunology

Volumn 18, Issue 6, 2011, Pages 940-946

  Crum Cianflone, Nancy F ^a,b   Roediger, Mollie ^a,c   Eberly, Lynn E ^a,c   Ganesan, Anuradha ^a,d   Weintrob, Amy ^a,d   Johnson, Erica ^a,e   Agan, Brian K ^a   Banks, Susan ^f   Bavaro, Mary ^f   Chun, Helen ^f   Decker, Cathy ^f   Eggleston, Conner ^f   Fraser, Susan ^f   Hairston, Heather ^f   Hartzell, Josh ^f   Johnson, Arthur ^f   Landrum, Michael ^f   Lifson, Alan ^f   Linfesty, Michelle ^f   Macalino, Grace ^f   Maguire, Jason ^f   Merritt, Scott ^f   O'Connell, Robert ^f   Okulicz, Jason ^f   Peel, Sheila ^f   Powers, John ^f   Whitman, Timothy ^f   Wortmann, Glenn ^f   Zapor, Michael ^f   more..

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^f San Antonio Military Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD56 ANTIGEN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MILITARY RESEARCH; OBESITY; PRIORITY JOURNAL; SEROCONVERSION;

ADULT; BODY MASS INDEX; BODY WEIGHT; FEMALE; HIV INFECTIONS; HUMANS; LEUKOCYTE COUNT; MALE; PROSPECTIVE STUDIES; UNITED STATES;

EID: 79957974065     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00020-11     Document Type: Article

References (49)

1. Adeyemi, O. M., S. Vibhakar, and A. T. Evans. 2009. Obesity and lymphocyte subsets in virologically suppressed HIV-infected patients. Metabolism 58:1285-1287.
2. Amorosa, V., et al. 2005. A tale of 2 epidemics. The intersection between obesity and HIV infection in Philadelphia. J. Acquir. Immune Defic. Syndr. 39:557-561.
3. Bahceci, M., et al. 2007. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J. Endocrinol. Invest. 30:210-214.
4. Boger, M. S., et al. 2009. Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study. J. Acquir. Immune Defic. Syndr. 52:480-487.
5. Bray, G. A. 1985. Complications of obesity. Ann. Intern. Med. 103:1052-1062.
6. Crum-Cianflone, N., R. Tejidor, S. Medina, I. Barahona, and A. Ganesan. 2008. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS 22:925-930.
7. Crum-Cianflone, N. F., et al. 2010. Obesity among HIV-infected persons: impact of weight on CD4 cell count. AIDS 24:1069-1072.
8. Di Leo, A., et al. 2009. Surgical site infections in an Italian surgical ward: a prospective study. Surg. Infect. (Larchmt.) 10:533-538.
9. Dworkin, M. S., and J. M. Williamson. 2003. AIDS wasting syndrome: trends, influence on opportunistic infections, and survival. J. Acquir. Immune Defic. Syndr. 33:267-273.
10. Eliakim, A., C. Schwindt, F. Zaldivar, P. Casali, and D. M. Cooper. 2006. Reduced tetanus antibody titers in overweight children. Autoimmunity 39:137-141.
11. Falagas, M. E., A. P. Athanasoulia, G. Peppas, and D. E. Karageorgopoulos. 2009. Effect of body mass index on the outcome of infections: a systematic review. Obes. Rev. 10:280-289.
12. Fasol, R., et al. 1992. The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac. Cardiovasc. Surg. 40:126-129.
13. Flegal, K. M., B. I. Graubard, D. F. Williamson, and M. H. Gail. 2005. Excess deaths associated with underweight, overweight, and obesity. JAMA 293:1861-1867.
14. Fontaine, K. R., D. T. Redden, C. Wang, A. O. Westfall, and D. B. Allison. 2003. Years of life lost due to obesity. JAMA 289:187-193.
15. Ford, E. S. 1999. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971-1977. (Pubitemid 30433974)
16. Giorgi, J. V., et al. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179:859-870.
17. Hanrahan, C. F., et al. 2010. Body mass index and risk of tuberculosis and death. AIDS 24:1501-1508.
18. Hodgson, L. M., et al. 2001. Wasting and obesity in HIV outpatients. AIDS 15:2341-2342.
19. Huttunen, R., and J. Syrjänen. 2010. Obesity and the outcome of infection. Lancet Infect. Dis. 10:442-443.
20. Jones, C. Y., et al. 2003. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort and changes in body mass index in women in the HIV epidemiology research study cohort. Clin. Infect. Dis. 37:S69-S80.
21. Karlsson, E. A., P. A. Sheridan, and M. A. Beck. 2010. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J. Immunol. 184:3127-3133.
22. Lord, G. M., G. Matarese, J. K. Howard, S. R. Bloom, and R. I. Lechler. 2002. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J. Leukoc. Biol. 72:330-338.
23. Lord, G. M., et al. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppresion. Nature 394:897-901. (Pubitemid 28410912)
24. Lynch, L. A., et al. 2009. Are natural killer cells protecting the metabolically healthy obese patient? Obesity 17:601-605.
25. Martí, A., A. Marcos, and J. A. Martínez. 2001. Obesity and immune function relationships. Obes. Rev. 2:131-140.
26. Mocroft, A., et al. 1999. Changes in AIDS-defining illnesses in a London clinic, 1987-1998. J. Acquir. Immune Defic. Syndr. 21:401-407.
27. Mulligan, K., et al. 2010. Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. Clin. Infect. Dis. 50:106-114.
28. Nieman, D. C., et al. 1999. Influence of obesity on immune function. J. Amer. Diet. Assoc. 99:294-299.
29. Obesity Research. 1998. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults; the evidence report. Obes. Res. 6:51S-209S.
30. O'Rourke, R. W., et al. 2005. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes. Surg. 15:1463-1468.
31. O'Rourke, R. W., et al. 2006. Alterations in peripheral blood lymphocyte cytokine expression in obesity. Clin. Exp. Immunol. 146:39-46.
32. Ortiz, V., M. Berenguer, J. M. Rayón, D. Carrasco, and J. Berenguer. 2002. Contribution of obesity to hepatitis C-related fibrosis progression. Am. J. Gastroenterol. 97:2408-2414.
33. Palella, F., et al. 2006. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J. Acquir. Immune Defic. Syndr. 43:27-34.
34. Palenicek, J. P., et al. 1995. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J. Acquir. Immune Defic. Syndr. 10:366-373.
35. Parikh, N. I., et al. 2007. Increasing trends in incidence of overweight and obesity over 5 decades. Am. J. Med. 120:242-250.
36. Reuman, P. D., P. Kubilis, W. Hurni, L. Brown, and D. Nalin. 1997. The effect of age and weight on the response to formalin inactivated, alumadjuvanted hepatitis A vaccine in healthy adults. Vaccine 15:1157-1161. (Pubitemid 27357202)
37. Shor-Posner, G., et al. 2000. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J. Acquir. Immune Defic. Syndr. 23:81-88.
38. Shuter, J., C. J. Chang, and R. S. Klein. 2001. Prevalence and predictive value of overweight in an urban HIV care clinic. J. Acquir. Immune Defic. Syndr. 26:291-297.
39. Tanaka, S. I., F. Isoda, Y. Ishihara, M. Kimura, and T. Yamakawa. 2001. T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective. Clin. Endocrinol. 54:347-354.
40. Tanaka, S., et al. 1993. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int. J. Obes. Relat. Metab. Disord. 17:631-636.
41. Tsatsanis, C., A. N. Margioris, and D. P. Kontoyiannis. 2010. Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. J. Infect. Dis. 202:459-460.
42. Villareal, D. T., C. M. Apovian, R. F. Kushner, and S. Klein. 2005. American Society for Nutrition; NAASO, The Obesity Society. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes. Res. 13:1849-1863.
43. Visser, M., L. M. Bouter, G. M. McQuillan, M. H. Wener, and T. B. Harris. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135.
44. Weintrob, A. C., et al. 2009. Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care. J. Acquir. Immune Defic. Syndr. 52:574-580.
45. Wheeler, D. A., et al. 1998. Weight loss as a predictor of survival and disease progression in HIV infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:80-85.
46. Wilson, P. W., R. B. D'Agostino, L. Sullivan, H. Parise, and W. B. Kannel. 2002. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 162:1867-1872.
47. Womack, J., et al. 2007. Obesity and immune cell counts in women. Metabolism 56:998-1004. (Pubitemid 46890984)
48. Wood, R. C., et al. 1993. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 270:2935-2939. (Pubitemid 24000799)
49. World Health Organization. 1995. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. WHO Technical Report Series 854. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/trs/WHO-TRS-854.pdf.